Enzon Pharmaceuticals Overview
Enzon Pharmaceuticals Discounted Cash Flow
DCF Analysis for ENZN.
Get informed when a big investor buys or sells
+ FollowFair Value
$0.63
Current Fair Value
$0.63
↓ 88.8% Downside
Overvalued by 88.8% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison